Effect of Vasoactive Therapy on Cerebral Circulation

Critical Care Clinics

Volumn 22, Issue 2, 2006, Pages 221-243

  Rhoney, Denise H ^a   Liu DeRyke, Xi ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN HEXETIL; CAPTOPRIL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; ENALAPRILAT; ESMOLOL; FENOLDOPAM; GLYCERYL TRINITRATE; HYDRALAZINE; LABETALOL; LOSARTAN; METOPROLOL; NICARDIPINE; NIFEDIPINE; NITROPRUSSIDE SODIUM; OXPRENOLOL; SOTALOL; TRIMETAPHAN; VASOACTIVE AGENT;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE MONITORING; BRADYCARDIA; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; CARDIOVASCULAR AUTOREGULATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CYANIDE POISONING; DIZZINESS; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG TOLERANCE; FLUSHING; HEADACHE; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPERTENSIVE CRISIS; HYPOTENSION; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; INTRAOCULAR HYPERTENSION; MEAN ARTERIAL PRESSURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; STROKE; TACHYCARDIA; TACHYPHYLAXIS; TREATMENT PLANNING;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR CIRCULATION; HUMANS; HYPERTENSION;

EID: 33646128937     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2006.02.009     Document Type: Review

References (107)

1. American Heart Association. Heart disease and stroke statistics-2005 update (2005), American Heart Association, Dallas (TX)
2. Leonardi-Bee J., Bath P.M., Phillips S.J., et al. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 33 5 (2002) 1315-1320
3. Britton M., Carlsson A., and de Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke 17 5 (1986) 861-864
4. Wallace J.D., and Levy L.L. Blood pressure after stroke. JAMA 246 19 (1981) 2177-2180
5. Lang E.W., Lagopoulos J., Griffith J., et al. Cerebral vasomotor reactivity testing in head injury: the link between pressure and flow. J Neurol Neurosurg Psychiatry 74 8 (2003) 1053-1059
6. Astrup J., Siesjo B.K., and Symon L. Thresholds in cerebral ischemia-the ischemic penumbra. Stroke 12 6 (1981) 726-730
7. Eames P.J., Blake M.J., Dawson S.L., et al. Dynamic cerebral autoregulation and beat to beat blood pressure control are impaired in acute ischaemic stroke. J Neurol Neurosurg Psychiatry 72 4 (2002) 467-472
8. Okumura K., Ohya Y., Maehara A., et al. Effects of blood pressure levels on case fatality after acute stroke. J Hypertens 23 6 (2005) 1217-1223
9. Rordorf G., Koroshetz W.J., Ezzeddine M.A., et al. A pilot study of drug-induced hypertension for treatment of acute stroke. Neurology 56 9 (2001) 1210-1213
10. Chalela J.A., Dunn B., Todd J.W., et al. Induced hypertension improves cerebral blood flow in acute ischemic stroke. Neurology 64 11 (2005) 1979
11. Willmot M., Leonardi-Bee J., and Bath P.M. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 43 1 (2004) 18-24
12. Adams Jr. H.P., Adams R.J., Brott T., et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 34 4 (2003) 1056-1083
13. Adams H., Adams R., Del Zoppo G., et al. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update: a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 36 4 (2005) 916-923
14. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Blood pressure, cholesterol, and stroke in Eastern Asia. Lancet 352 9143 (1998) 1801-1807
15. Dandapani B.K., Suzuki S., Kelley R.E., et al. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 26 1 (1995) 21-24
16. Kazui S., Minematsu K., Yamamoto H., et al. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke 28 12 (1997) 2370-2375
17. Leira R., Davalos A., Silva Y., et al. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology 63 3 (2004) 461-467
18. Ohwaki K., Yano E., Nagashima H., et al. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke 35 6 (2004) 1364-1367
19. Fujii Y., Takeuchi S., Sasaki O., et al. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 29 6 (1998) 1160-1166
20. Qureshi A.I., Wilson D.A., Hanley D.F., et al. Pharmacologic reduction of mean arterial pressure does not adversely affect regional cerebral blood flow and intracranial pressure in experimental intracerebral hemorrhage. Crit Care Med 27 5 (1999) 965-971
21. Kuwata N., Kuroda K., Funayama M., et al. Dysautoregulation in patients with hypertensive intracerebral hemorrhage. A SPECT study. Neurosurg Rev 18 4 (1995) 237-245
22. Carhuapoma J.R., Wang P.Y., Beauchamp N.J., et al. Diffusion-weighted MRI and proton MR spectroscopic imaging in the study of secondary neuronal injury after intracerebral hemorrhage. Stroke 31 3 (2000) 726-732
23. Kidwell C.S., Saver J.L., Mattiello J., et al. Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage. Neurology 57 9 (2001) 1611-1617
24. Zazulia A.R., Diringer M.N., Videen T.O., et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab 21 7 (2001) 804-810
25. Powers W.J., Zazulia A.R., Videen T.O., et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology 57 1 (2001) 18-24
26. Schellinger P.D., Fiebach J.B., Hoffmann K., et al. Stroke MRI in intracerebral hemorrhage: is there a perihemorrhagic penumbra?. Stroke 34 7 (2003) 1674-1679
27. Intensive blood pressure reduction in acute cerebral haemorrhage. NCT00226096. Available at:. www.clinicaltrial.gov Accessed January 2006
28. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 6 (2003) 1206-1252
29. Erstad B.L., and Barletta J.F. Treatment of hypertension in the perioperative patient. Ann Pharmacother 34 1 (2000) 66-79
30. Varon J., and Marik P.E. The diagnosis and management of hypertensive crises. Chest 118 1 (2000) 214-227
31. Abdelwahab W., Frishman W., and Landau A. Management of hypertensive urgencies and emergencies. J Clin Pharmacol 35 8 (1995) 747-762
32. Sipe E.K., Trienski T.L., and Porter J.M. Cyanide toxicity in the surgical intensive care unit: a case report. Am Surg 67 7 (2001) 684-686
33. Alaniz C., and Watts B. Monitoring cyanide toxicity in patients receiving nitroprusside therapy. Ann Pharmacother 39 2 (2005) 388-389
34. Cottrell J.E., Casthely P., Brodie J.D., et al. Mechanism and prevention of tachyphylaxis and cyanide toxicosis after nitroprusside-induced hypotension. Surg Forum 29 (1978) 308-310
35. Cottrell J.E., Patel K., Turndorf H., et al. Intracranial pressure changes induced by sodium nitroprusside in patients with intracranial mass lesions. J Neurosurg 48 3 (1978) 329-331
36. Griswold W.R., Reznik V., and Mendoza S.A. Nitroprusside-induced intracranial hypertension. JAMA 246 23 (1981) 2679-2680
37. Anile C., Zanghi F., Bracali A., et al. Sodium nitroprusside and intracranial pressure. Acta Neurochir (Wien) 58 3-4 (1981) 203-211
38. Larsen R., Teichmann J., Hilfiker O., et al. Nitroprusside-hypotension: cerebral blood flow and cerebral oxygen consumption in neurosurgical patients. Acta Anaesthesiol Scand 26 4 (1982) 327-330
39. Griffiths D.P., Cummins B.H., Greenbaum R., et al. Cerebral blood flow and metabolism during hypotension induced with sodium nitroprusside. Br J Anaesth 46 9 (1974) 671-679
40. Fitch W., Ferguson G.G., Sengupta D., et al. Autoregulation of cerebral blood flow during controlled hypotension in baboons. J Neurol Neurosurg Psychiatry 39 10 (1976) 1014-1022
41. Stoyka W.W., and Schutz H. The cerebral response to sodium nitroprusside and trimethaphan controlled hypotension. Can Anaesth Soc J 22 3 (1975) 275-283
42. Turner J.M., Powell D., Gibson R.M., et al. Intracranial pressure changes in neurosurgical patients during hypotension induced with sodium nitroprusside or trimetaphan. Br J Anaesth 49 5 (1977) 419-425
43. Ivankovich A.D., Miletich D.J., Albrecht R.F., et al. Sodium nitroprusside and cerebral blood flow in the anesthetized and unanesthetized goat. Anesthesiology 44 1 (1976) 21-26
44. Crockard H.A., Brown F.D., and Mullan J.F. Effects of trimethaphan and sodium nitroprusside on cerebral blood flow in rhesus monkeys. Acta Neurochir (Wien) 35 1-3 (1976) 85-89
45. Brown F.D., Hanlon K., Crockard H.A., et al. Effect of sodium nitroprusside on cerebral blood flow in conscious human beings. Surg Neurol 7 2 (1977) 67-70
46. Miller C.L., Lampard D.G., Griffiths R.I., et al. Local cerebral blood flow and the electrocorticogram during sodium nitroprusside hypotension. Anaesth Intensive Care 6 4 (1978) 290-296
47. Miletich D.J., Gil K.S., Albrecht R.F., et al. Intracerebral blood flow distribution during hypotensive anesthesia in the goat. Anesthesiology 53 3 (1980) 210-214
48. Brown M.J. Vasodilator drugs: systemic and regional considerations. Anaesth Intensive Care 8 3 (1980) 310-317
49. Kistler J.P., Lees R.S., Candia G., et al. Intravenous nitroglycerin in experimental cerebral vasospasm. A preliminary report. Stroke 10 1 (1979) 26-29
50. Lagerkranser M. Effects of nitroglycerin on intracranial pressure and cerebral blood flow. Acta Anaesthesiol Scand Suppl 97 (1992) 34-36
51. Gagnon R.L., Marsh M.L., Smith R.W., et al. Intracranial hypertension caused by nitroglycerin. Anesthesiology 51 1 (1979) 86-87
52. Ohar J.M., Fowler A.A., Selhorst J.B., et al. Intravenous nitroglycerin-induced intracranial hypertension. Crit Care Med 13 10 (1985) 867-868
53. Griffith D.N., James I.M., Newbury P.A., et al. The effect of beta-adrenergic receptor blocking drugs on cerebral blood flow. Br J Clin Pharmacol 7 5 (1979) 491-494
54. Olsen K.S., Svendsen L.B., Larsen F.S., et al. Effect of labetalol on cerebral blood flow, oxygen metabolism and autoregulation in healthy humans. Br J Anaesth 75 1 (1995) 51-54
55. Patel R.V., Kertland H.R., Jahns B.E., et al. Labetalol: response and safety in critically ill hemorrhagic stroke patients. Ann Pharmacother 27 2 (1993) 180-181
56. Larive L., Rhoney D., Parker D., et al. Acute blood pressure management in ischemic and hemorrhagic stroke [abstract 22]. Crit Care Med 31 Suppl (2003) S495
57. Haas C.E., and LeBlanc J.M. Acute postoperative hypertension: a review of therapeutic options. Am J Health Syst Pharm 61 16 (2004) 1661-1673 [quiz: 74-5]
58. Halpern N.A., Goldberg M., Neely C., et al. Postoperative hypertension: a multicenter, prospective, randomized comparison between intravenous nicardipine and sodium nitroprusside. Crit Care Med 20 12 (1992) 1637-1643
59. Dorman T., Thompson D.A., Breslow M.J., et al. Nicardipine versus nitroprusside for breakthrough hypertension following carotid endarterectomy. J Clin Anesth 13 1 (2001) 16-19
60. Sabbatini M., Bellagamba G., Casado A., et al. Protective effect of treatment with nicardipine on cerebrovascular tree of spontaneously hypertensive rats. Clin Exp Hypertens 23 1-2 (2001) 143-155
61. Suzuki S., Ohtsuka S., Ishikawa K., et al. Effects of nicardipine on coronary, vertebral and renal arterial flows in patients with essential hypertension. Hypertens Res 26 3 (2003) 193-199
62. Gaab M.R., Czech T., and Korn A. Intracranial effects of nicardipine. Br J Clin Pharmacol 20 Suppl 1 (1985) 67S-74S
63. Nishiyama T., Yokoyama T., Matsukawa T., et al. Continuous nicardipine infusion to control blood pressure after evacuation of acute cerebral hemorrhage. Can J Anaesth 47 12 (2000) 1196-1201
64. DeRyke-Liu X., Parker D., and Rhoney D. Nicardipine vs. labetalol for acute blood pressure control after stroke. Crit Care Med 33 (2005) A103
65. Flamm E.S. The potential use of nicardipine in cerebrovascular disease. Am Heart J 117 1 (1989) 236-242
66. Sabbatini M., Strocchi P., and Amenta F. Nicardipine and treatment of cerebrovascular diseases with particular reference to hypertension-related disorders. Clin Exp Hypertens 17 5 (1995) 719-750
67. McAreavey D., and Robertson J.I. Angiotensin converting enzyme inhibitors and moderate hypertension. Drugs 40 3 (1990) 326-345
68. Klein L., O'Connor C.M., Gattis W.A., et al. Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations. Am J Cardiol 91 9A (2003) 18F-40F
69. Paulson O.B., Jarden J.O., Godtfredsen J., et al. Cerebral blood flow in patients with congestive heart failure treated with captopril. Am J Med 76 5B (1984) 91-95
70. Waldemar G., Vorstrup S., Andersen A.R., et al. Angiotensin-converting enzyme inhibition and regional cerebral blood flow in acute stroke. J Cardiovasc Pharmacol 14 5 (1989) 722-729
71. Rajagopalan B., Raine A.E., Cooper R., et al. Changes in cerebral blood flow in patients with severe congestive cardiac failure before and after captopril treatment. Am J Med 76 5B (1984) 86-90
72. Barry D.I., Paulson O.B., Jarden J.O., et al. Effects of captopril on cerebral blood flow in normotensive and hypertensive rats. Am J Med 76 5B (1984) 79-85
73. Kobayashi S., Yamaguchi S., Okada K., et al. The effect of enalapril maleate on cerebral blood flow in chronic cerebral infarction. Angiology 43 5 (1992) 378-388
74. Dyker A.G., Grosset D.G., and Lees K. Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke. Stroke 28 3 (1997) 580-583
75. Walters M.R., Bolster A., Dyker A.G., et al. Effect of perindopril on cerebral and renal perfusion in stroke patients with carotid disease. Stroke 32 2 (2001) 473-478
76. Paulson O.B., Waldemar G., Andersen A.R., et al. Role of angiotensin in autoregulation of cerebral blood flow. Circulation 77 6 Pt 2 (1988) I55-I58
77. Waldemar G., and Paulson O.B. Angiotensin converting enzyme inhibition and cerebral circulation-a review. Br J Clin Pharmacol 28 Suppl 2 (1989) 177S-182S
78. Lisk D.R., Grotta J.C., Lamki L.M., et al. Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography. Arch Neurol 50 8 (1993) 855-862
79. Patel R.V., Ramadan N.M., Levine S.R., et al. Effects of ramipril and enalapril on cerebral blood flow in elderly patients with asymptomatic carotid artery occlusive disease. J Cardiovasc Pharmacol 28 1 (1996) 48-52
80. Schmidt J.F., Andersen A.R., Paulson O.B., et al. Angiotensin converting enzyme inhibition, CBF autoregulation, and ICP in patients with normal-pressure hydrocephalus. Acta Neurochir (Wien) 106 1-2 (1990) 9-12
81. Schrader J., Luders S., Kulschewski A., et al. The ACCESS study: evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke 34 7 (2003) 1699-1703
82. Nazir F.S., Overell J.R., Bolster A., et al. The effect of losartan on global and focal cerebral perfusion and on renal function in hypertensives in mild early ischaemic stroke. J Hypertens 22 5 (2004) 989-995
83. Tsikouris J.P., and Cox C.D. Pharmacologic blockade of the renin-angiotensin system: vascular benefits beyond commonly understood pharmacologic actions. Pharmacotherapy 23 9 (2003) 1141-1152
84. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358 9287 (2001) 1033-1041
85. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 362 9395 (2003) 1527-1535
86. Dahlof B., Devereux R.B., Kjeldsen S.E., et al. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study: a randomised trial against atenolol. Lancet 359 9311 (2002) 995-1003
87. Fournier A., Messerli F.H., Achard J.M., et al. Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent randomized clinical trials. J Am Coll Cardiol 43 8 (2004) 1343-1347
88. Fernandez L.A., Spencer D.D., and Kaczmar Jr. T. Angiotensin II decreases mortality rate in gerbils with unilateral carotid ligation. Stroke 17 1 (1986) 82-85
89. Makino I., Shibata K., Ohgami Y., et al. Transient upregulation of the AT2 receptor mRNA level after global ischemia in the rat brain. Neuropeptides 30 6 (1996) 596-601
90. Groth W., Blume A., Gohlke P., et al. Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats. J Hypertens 21 11 (2003) 2175-2182
91. Nishimura Y., Ito T., and Saavedra J.M. Angiotensin II AT(1) blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 31 10 (2000) 2478-2486
92. Yamakawa H., Jezova M., Ando H., et al. Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition. J Cereb Blood Flow Metab 23 3 (2003) 371-380
93. Hosomi N., Nishiyama A., Ban C.R., et al. Angiotensin type 1 receptor blockage improves ischemic injury following transient focal cerebral ischemia. Neuroscience 134 1 (2005) 225-231
94. Dai W.J., Funk A., Herdegen T., et al. Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke 30 11 (1999) 2391-2398 [discussion: 2398-9]
95. Engelhorn T., Goerike S., Doerfler A., et al. The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats. J Cereb Blood Flow Metab 24 4 (2004) 467-474
96. Hirschl M.M., Binder M., Bur A., et al. Impact of the renin-angiotensin-aldosterone system on blood pressure response to intravenous enalaprilat in patients with hypertensive crises. J Hum Hypertens 11 3 (1997) 177-183
97. Oparil S., Aronson S., Deeb G.M., et al. Fenoldopam: a new parenteral antihypertensive: consensus roundtable on the management of perioperative hypertension and hypertensive crises. Am J Hypertens 12 7 (1999) 653-664
98. Murphy M.B., Murray C., and Shorten G.D. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. N Engl J Med 345 21 (2001) 1548-1557
99. Prielipp R.C., Wall M.H., Groban L., et al. Reduced regional and global cerebral blood flow during fenoldopam-induced hypotension in volunteers. Anesth Analg 93 1 (2001) 45-52
100. Hennes H.J., and Jantzen J.P. Effects of fenoldopam on intracranial pressure and hemodynamic variables at normal and elevated intracranial pressure in anesthetized pigs. J Neurosurg Anesthesiol 6 3 (1994) 175-181
101. Kruszyna H., Kruszyna R., Smith R.P., et al. Red blood cells generate nitric oxide from directly acting, nitrogenous vasodilators. Toxicol Appl Pharmacol 91 3 (1987) 429-438
102. Johansson B.B., Auer L.M., and Trummer U.G. Pial vascular reaction to intravenous dihydralazine in the cat. Stroke 11 4 (1980) 369-371
103. Overgaard J., and Skinhoj E. A paradoxical cerebral hemodynamic effect of hydralazine. Stroke 6 4 (1975) 402-410
104. Skinhoj E., and Overgaard J. Effect of dihydralazine on intracranial pressure in patients with severe brain damage. Acta Med Scand Suppl 678 (1983) 83-87
105. James D.J., and Bedford R.F. Hydralazine for controlled hypotension during neurosurgical operations. Anesth Analg 61 12 (1982) 1016-1019
106. O'Malley K., Segal J.L., Israili Z.H., et al. Duration of hydralazine action in hypertension. Clin Pharmacol Ther 18 5 Pt 1 (1975) 581-586
107. Broderick J.P., Adams Jr. H.P., Barsan W., et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council. American Heart Association. Stroke 30 4 (1999) 905-915